Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM
Sage Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 67.49M | 45.22M | 81.02M | 99.63M | 101.23M | 173.99M | 70.99M | 148.71M | 121.42M | 206.56M | 162.7M | 199.83M | 206.51M | 178.67M | 294.23M | 422.17M | 514.16M | 899.25M |
Short-Term Investments | 298.08M | 378.63M | 423.4M | 469.53M | 546.89M | 544.36M | 682.19M | 727.34M | 881.2M | 923.03M | 1.11B | 1.19B | 1.31B | 1.45B | 1.45B | 1.42B | 1.4B | 1.1B |
Long-Term Investments | 1.45M | n/a | n/a | n/a | n/a | 1.5M | n/a | 1.33M | 1.33M | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M |
Other Long-Term Assets | 1.76M | 4.06M | 4.28M | 5.17M | 7.8M | 6.22M | 6.55M | 6.59M | 68.3M | 4.25M | 69.26M | 4.91M | 4.91M | 4.59M | 4.25M | 3.88M | 3.6M | 3.39M |
Receivables | 26.57M | 10.73M | 9.13M | 14.87M | n/a | 14.11M | 83.01M | 22.51M | 15.09M | 15M | 13.66M | 18.45M | 23.72M | 19.8M | 18.51M | 24.18M | 48.44M | 24.77M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -61.41M | -15M | -64.49M | n/a | n/a | n/a | 1.4M | n/a | n/a | n/a |
Other Current Assets | 16.94M | 19.89M | 17.75M | 20.96M | 40.02M | 27.92M | 33.16M | 34.7M | 46.32M | 58.85M | 50.83M | n/a | 41.45M | n/a | n/a | 34.34M | n/a | n/a |
Total Current Assets | 409.08M | 454.48M | 531.3M | 604.99M | 686.81M | 755.44M | 869.35M | 933.27M | 1B | 1.2B | 1.27B | 1.47B | 1.58B | 1.68B | 1.8B | 1.9B | 1.99B | 2.05B |
Property-Plant & Equipment | 10.63M | 11.13M | 11.64M | 12.27M | 2.49M | 4.44M | 6.38M | 8.47M | 10.04M | 11.72M | 13.43M | 14.79M | 16.32M | 17.6M | 19.13M | 20.34M | 22.01M | 24.17M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 13.84M | 15.19M | 15.92M | 17.45M | 10.29M | 12.16M | 12.93M | 16.39M | 79.67M | 17.25M | 83.95M | 20.97M | 22.49M | 23.46M | 24.64M | 25.48M | 26.88M | 28.83M |
Total Assets | 422.92M | 469.67M | 547.22M | 622.43M | 697.11M | 767.6M | 882.28M | 949.66M | 1.08B | 1.22B | 1.36B | 1.49B | 1.6B | 1.71B | 1.83B | 1.93B | 2.02B | 2.08B |
Account Payables | 692K | 5.43M | 12.7M | 7.13M | 8.65M | 6.48M | 10.32M | 11.14M | 9.28M | 12.26M | 18.95M | 7.08M | 5.41M | 7.13M | 10.45M | 4.73M | 2.92M | 3.29M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.88M | n/a | n/a | 83K | 1.41M | n/a | n/a | 6.97M | 7.72M | 7.68M | 7.64M | 7.6M | 7.56M | 7.52M | 7.47M | 7.41M | 7.36M | 7.31M |
Other Current Liabilities | 31.32M | 42.53M | 14.84M | 36.11M | 43.27M | 44.92M | 21.34M | 93.83M | 52.88M | 47.19M | 35.65M | 57.23M | 54.01M | 48.13M | 41.19M | 47.99M | 45.98M | 40.47M |
Total Current Liabilities | 44.64M | 49.78M | 71.61M | 60.41M | 69.04M | 61.8M | 82.75M | 133M | 96.81M | 84.69M | 99.26M | 99.69M | 89.24M | 77.7M | 85.19M | 78.94M | 71.9M | 62.01M |
Long-Term Debt | 9.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.76M | 4.49M | 6.16M | 7.8M | 9.4M | 10.96M | 12.48M | 13.96M | 15.41M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 102K | -2.66M | -4.39M | -6.06M | -7.7M | -9.29M | -10.86M | -12.38M | -13.86M | -15.41M |
Total Long-Term Liabilities | 9.54M | 10.04M | 10.52M | 10.19M | n/a | n/a | n/a | n/a | 1.1M | 2.87M | 4.59M | 6.26M | 7.9M | 9.5M | 11.06M | 12.58M | 14.06M | 15.41M |
Total Liabilities | 54.19M | 59.82M | 82.13M | 70.6M | 69.04M | 61.8M | 82.75M | 133M | 97.91M | 87.56M | 103.85M | 105.95M | 97.14M | 87.2M | 96.26M | 91.53M | 85.96M | 77.42M |
Total Debt | 11.42M | 11.86M | 11.84M | 10.27M | 1.41M | 3.31M | 5.17M | 6.97M | 8.73M | 10.45M | 12.13M | 13.77M | 15.36M | 16.92M | 18.43M | 19.89M | 21.32M | 22.72M |
Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K |
Retained Earnings | -3.08B | -3.03B | -2.97B | -2.87B | -2.78B | -2.68B | -2.57B | -2.54B | -2.34B | -2.17B | -2.03B | -1.88B | -1.74B | -1.62B | -1.5B | -1.37B | -1.24B | -1.13B |
Comprehensive Income | 15K | 142K | 244K | 901K | -691K | -787K | -814K | -3.73M | -5.64M | -5.09M | -10.21M | -14.88M | -13.87M | -11.2M | -2.66M | -306K | -285K | -236K |
Shareholders Equity | 368.74M | 409.85M | 465.09M | 551.84M | 628.06M | 705.8M | 799.53M | 816.66M | 984.38M | 1.13B | 1.25B | 1.38B | 1.5B | 1.62B | 1.73B | 1.84B | 1.93B | 2B |
Total Investments | 299.54M | 378.63M | 423.4M | 469.53M | 546.89M | 545.86M | 682.19M | 727.34M | 881.2M | 923.03M | 1.11B | 1.19B | 1.31B | 1.45B | 1.45B | 1.42B | 1.4B | 1.1B |